← Back to headlines
Alnylam Pharmaceuticals Faces Target Trims Amid Growth Faith
Analysts have trimmed their targets for Alnylam Pharmaceuticals, Inc. (ALNY) but maintain faith in the company's growth prospects for 2026.
19 Feb, 05:01 — 19 Feb, 05:01
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Amit Jain's Shark Tank India Investments Outperform Big Spenders
2m ago
United Group Media Restructuring Without Minority Shareholder Consent
5m ago
American Girl Celebrates 40th Anniversary Amidst Mattel's Efforts to Modernize Brand
8m ago
EU-India FTA opens doors to trade, AI, resilient supply chains: Austrian official
12m ago